Biogen (BIIB) Net Margin (2009 - 2026)

Biogen has reported Net Margin for 18 years, with the latest figure at 3.56% in Q2 2026.

• On a quarterly basis, Net Margin fell 2043.0% year-over-year to 3.56% in Q2 2026; TTM through Jun 2026 was 8.32%, a 699.0% decrease from a year earlier, with the FY2025 full-year figure at 13.07%, down 380.0% from the prior year.
• Net Margin was 3.56% for Q2 2026 at Biogen, down from 12.89% in the prior quarter.
• The five-year high for Net Margin was 45.24% in Q3 2022, with the low at 2.7% in Q3 2023.
• Average Net Margin over 5 years is 16.55%, with a median of 15.75% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Net Margin jumped 3383 bps in 2022, then plunged 4794 bps in 2023.
• Over 5 years, Net Margin stood at 21.6% in 2022, then sank by 52 bps to 10.43% in 2023, then climbed by 4 bps to 10.86% in 2024, then plunged by 120 bps to 2.15% in 2025, then jumped by 266 bps to 3.56% in 2026.
• The last three Net Margin figures came in at 3.56% (Q2 2026), 12.89% (Q1 2026), and 2.15% (Q4 2025), per Business Quant data.